Table 2.
no ACLF vs ACLF patients | Survival vs Death in 30 days | ||||||
---|---|---|---|---|---|---|---|
miRNA | P-value | FC | Regulation | miRNA | P-value | FC | Regulation |
let-7a-5p | 0.004 | 10 | down | let-7a-5p | 0.009 | 13 | down |
let-7b-5p | 0.007 | 6 | down | let-7f-5p | 0.012 | 9 | down |
let-7g-5p | 0.009 | 14 | down | let-7g-5p | 0.008 | 18 | down |
miR-106b-5p | 0.007 | 10 | down | miR-106b-5p | 0.006 | 13 | down |
miR-107 | 0.001 | 11 | down | miR-126-3p | 0.004 | 14 | down |
miR-126-3p | 0.006 | 14 | down | miR-146a-5p | 0.012 | 9 | down |
miR-142-3p | 0.009 | 8 | down | miR-150-5p | 0.015 | 8 | down |
miR-150-5p | 0.005 | 7 | down | miR-15b-5p | 0.017 | 10 | down |
miR-15b-5p | 0.002 | 9 | down | miR-16-5p | 0.026 | 8 | down |
miR-16-5p | 0.006 | 8 | down | miR-17-5p | 0.011 | 12 | down |
miR-17-5p | 0.004 | 15 | down | miR-199a-3p | 0.009 | 10 | down |
miR-20a-5p | 0.012 | 18 | down | miR-19a-3p | 0.013 | 8 | down |
miR-223-3p | 0.002 | 7 | down | miR-19b-3p | 0.021 | 7 | down |
miR-25-3p | 0.005 | 16 | down | miR-20a-5p | 0.043 | 15 | down |
miR-27a-3p | 0.008 | 7 | down | miR-223-3p | 0.003 | 10 | down |
miR-328-5p | 0.003 | 6 | down | miR-23a-3p | 0.011 | 8 | down |
miR-451a | 0.004 | 10 | down | miR-24-3p | 0.092 | 9 | down |
miR-4530 | 0.002 | 7 | down | miR-25-3p | 0.026 | 11 | down |
miR-5703 | 0.001 | 7 | down | miR-328-5p | 0.017 | 6 | down |
miR-630 | 0.001 | 7 | down | miR-4515 | 0.018 | 8 | down |
miR-451a | 0.029 | 8 | down | ||||
miR-4530 | 0.009 | 7 | down | ||||
miR-4741 | 0.004 | 7 | down | ||||
miR-575 | 0.010 | 10 | down | ||||
miR-5787 | 0.019 | 7 | down | ||||
miR-6090 | 0.019 | 7 | down | ||||
miR-6752-5p | 0.008 | 6 | down |
It was considered only miRNAs with fold-change (FC) ≥ 6 and P-value < 0.05.